Clinical Trials Directory

Trials / Completed

CompletedNCT03076411

Pepsin in Patients With Functional Dyspepsia

A Non-interventional, Observational Study With a Fixed Combination of Pepsin and Amino Acid Hydrochloride in Patients With Functional Dyspepsia

Status
Completed
Phase
Study type
Observational
Enrollment
97 (actual)
Sponsor
Nordmark Arzneimittel GmbH & Co. KG · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This non-interventional, observational study investigates the course of symptoms in patients with functional dyspepsia under treatment with a fixed combination of pepsin and amino acid hydrochloride over a period of approximately 6 weeks. The change of the Gastrointestinal Symptom Score (GIS©) was the primary parameter for the assessment of efficacy and was performed at baseline, after 3 and 6 weeks of treatment respectively. Safety measures included recording of AEs and physical examination as well as measurement of vital signs. The aim was to observe 100 patients during the course of this non-interventional study.

Conditions

Interventions

TypeNameDescription
DRUGPepsin

Timeline

Start date
2012-01-11
Primary completion
2013-12-19
Completion
2015-06-16
First posted
2017-03-10
Last updated
2017-03-10

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03076411. Inclusion in this directory is not an endorsement.